241 related articles for article (PubMed ID: 8086012)
1. beta-Amyloid protein-induced Alzheimer's disease animal model.
Nitta A; Itoh A; Hasegawa T; Nabeshima T
Neurosci Lett; 1994 Mar; 170(1):63-6. PubMed ID: 8086012
[TBL] [Abstract][Full Text] [Related]
2. Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats.
Nabeshima T; Nitta A
Tohoku J Exp Med; 1994 Nov; 174(3):241-9. PubMed ID: 7761989
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration.
Nitta A; Fukuta T; Hasegawa T; Nabeshima T
Jpn J Pharmacol; 1997 Jan; 73(1):51-7. PubMed ID: 9032134
[TBL] [Abstract][Full Text] [Related]
4. NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by beta-amyloid protein in rats.
Tanaka T; Yamada K; Senzaki K; Narimatsu H; Nishimura K; Kameyama T; Nabeshima T
Eur J Pharmacol; 1998 Jul; 352(2-3):135-42. PubMed ID: 9716347
[TBL] [Abstract][Full Text] [Related]
5. [Nerve growth factor strategy and preparation of animal model for Alzheimer-type senile dementia].
Nabeshima T
Yakugaku Zasshi; 1995 Jul; 115(7):499-512. PubMed ID: 7562397
[TBL] [Abstract][Full Text] [Related]
6. [Trial to produce animal model of Alzheimer's disease by continuous infusion of beta-amyloid protein into the rat cerebral ventricle].
Nabeshima T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Oct; 15(5):411-8. PubMed ID: 8564734
[TBL] [Abstract][Full Text] [Related]
7. [Experimental techniques for developing new drugs acting on dementia (10)--Alzheimer's disease animal model induced by beta-amyloid protein].
Nitta A; Nabeshima T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):85-90. PubMed ID: 8905795
[TBL] [Abstract][Full Text] [Related]
8. Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and β-amyloid.
Deibel SH; Weishaupt N; Regis AM; Hong NS; Keeley RJ; Balog RJ; Bye CM; Himmler SM; Whitehead SN; McDonald RJ
Brain Res; 2016 Sep; 1646():12-24. PubMed ID: 27208489
[TBL] [Abstract][Full Text] [Related]
9. Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide.
Nakamura S; Murayama N; Noshita T; Annoura H; Ohno T
Brain Res; 2001 Sep; 912(2):128-36. PubMed ID: 11532428
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
Sharma S; Verma S; Kapoor M; Saini A; Nehru B
Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
[TBL] [Abstract][Full Text] [Related]
11. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat.
Wang R; Zhang HY; Tang XC
Eur J Pharmacol; 2001 Jun; 421(3):149-56. PubMed ID: 11516430
[TBL] [Abstract][Full Text] [Related]
12. Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease.
Yamada M; Chiba T; Sasabe J; Terashita K; Aiso S; Matsuoka M
Neuropsychopharmacology; 2008 Jul; 33(8):2020-32. PubMed ID: 17928813
[TBL] [Abstract][Full Text] [Related]
13. Propentofylline improves learning and memory deficits in rats induced by beta-amyloid protein-(1-40).
Yamada K; Tanaka T; Senzaki K; Kameyama T; Nabeshima T
Eur J Pharmacol; 1998 May; 349(1):15-22. PubMed ID: 9669491
[TBL] [Abstract][Full Text] [Related]
14. Co-morbid beta-amyloid toxicity and stroke produce impairments in an ambiguous context task in rats without any impairment in spatial working memory.
Keeley RJ; Hong NS; Fisher A; McDonald RJ
Neurobiol Learn Mem; 2015 Mar; 119():42-51. PubMed ID: 25576791
[TBL] [Abstract][Full Text] [Related]
15. The effects of melatonin and Ginkgo biloba extract on memory loss and choline acetyltransferase activities in the brain of rats infused intracerebroventricularly with beta-amyloid 1-40.
Tang F; Nag S; Shiu SY; Pang SF
Life Sci; 2002 Oct; 71(22):2625-31. PubMed ID: 12354581
[TBL] [Abstract][Full Text] [Related]
16. Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-β-Induced Alzheimer's Disease Model.
Paulo SL; Ribeiro-Rodrigues L; Rodrigues RS; Mateus JM; Fonseca-Gomes J; Soares R; Diógenes MJ; Solá S; Sebastião AM; Ribeiro FF; Xapelli S
J Alzheimers Dis; 2021; 82(3):1183-1202. PubMed ID: 34151790
[TBL] [Abstract][Full Text] [Related]
17. Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat.
Yamaguchi Y; Kawashima S
Eur J Pharmacol; 2001 Feb; 412(3):265-72. PubMed ID: 11166290
[TBL] [Abstract][Full Text] [Related]
18. Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer's disease: an exploration of underlying mechanisms.
Kiasalari Z; Heydarifard R; Khalili M; Afshin-Majd S; Baluchnejadmojarad T; Zahedi E; Sanaierad A; Roghani M
Psychopharmacology (Berl); 2017 Jun; 234(12):1841-1852. PubMed ID: 28303372
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
20. Satureja bachtiarica ameliorate beta-amyloid induced memory impairment, oxidative stress and cholinergic deficit in animal model of Alzheimer's disease.
Soodi M; Saeidnia S; Sharifzadeh M; Hajimehdipoor H; Dashti A; Sepand MR; Moradi S
Metab Brain Dis; 2016 Apr; 31(2):395-404. PubMed ID: 26638718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
